| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |